Published in BMJ on August 30, 1997
Attitudes and knowledge of hospital pharmacists to adverse drug reaction reporting. Br J Clin Pharmacol (2001) 1.77
Collecting and sharing information about harms. BMJ (2004) 1.58
Adverse drug reactions: finding the needle in the haystack. BMJ (1997) 1.03
Adverse drug reactions: back to the future. Br J Clin Pharmacol (2003) 1.00
Spontaneous reporting--of what? Clinical concerns about drugs. Br J Clin Pharmacol (1999) 0.82
The hitch-hiking effect of a favourable gene. Genet Res (1974) 34.74
Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A (1998) 16.04
A gene map of the human genome. Science (1996) 14.32
Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A (1986) 12.14
Career preferences of doctors who qualified in the United Kingdom in 1993 compared with those of doctors qualifying in 1974, 1977, 1980, and 1983. BMJ (1996) 12.00
Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science (2001) 9.09
Free recombination within Helicobacter pylori. Proc Natl Acad Sci U S A (1998) 8.06
MRC image processing programs. J Struct Biol (1996) 6.91
Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet (1994) 6.89
Tissue-specific and light-regulated expression of a pea nuclear gene encoding the small subunit of ribulose-1,5-bisphosphate carboxylase. EMBO J (1984) 6.53
Review of company postmarketing surveillance studies. BMJ (1992) 6.21
New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues. Proc Natl Acad Sci U S A (1981) 5.89
Horizontal transfer of penicillin-binding protein genes in penicillin-resistant clinical isolates of Streptococcus pneumoniae. Proc Natl Acad Sci U S A (1989) 5.65
Antimicrobial susceptibility patterns of Nocardia asteroides. Antimicrob Agents Chemother (1988) 5.56
Natural selection and the concept of a protein space. Nature (1970) 5.21
Evolution of genetic redundancy. Nature (1997) 4.95
Twenty five years of case finding and audit in a socially deprived community. BMJ (1991) 4.89
SYNTHESIS OF A COMPOUND IDENTICAL WITH THE L. CASEI FACTOR ISOLATED FROM LIVER. Science (1945) 4.80
Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom. Br J Clin Pharmacol (1995) 4.72
Estimating recombinational parameters in Streptococcus pneumoniae from multilocus sequence typing data. Genetics (2000) 4.61
The changing prevalence of asthma in school children. Clin Allergy (1971) 4.60
Monitoring adverse reactions to drugs. Br Med J (1977) 4.41
Career destinations in 1994 of United Kingdom medical graduates of 1983: results of a questionnaire survey. BMJ (1996) 4.27
The Structure and Synthesis of the Liver L. casei Factor. Science (1946) 4.08
Linkage disequilibrium and recombination in hominid mitochondrial DNA. Science (1999) 4.08
Electrical alternans and vulnerability to ventricular arrhythmias. N Engl J Med (1994) 4.00
Genetic linkage between hereditary hemochromatosis and HLA. Am J Hum Genet (1979) 3.96
The theory of games and the evolution of animal conflicts. J Theor Biol (1974) 3.93
A double-blind placebo-controlled study of buspirone in diazepam withdrawal in chronic benzodiazepine users. Br J Psychiatry (1990) 3.74
Polypeptide transforming growth factors isolated from bovine sources and used for wound healing in vivo. Science (1983) 3.51
Purification and properties of a type beta transforming growth factor from bovine kidney. Biochemistry (1983) 3.49
Isolation and identification of methanogen-specific DNA from blanket bog peat by PCR amplification and sequence analysis. Appl Environ Microbiol (1996) 3.47
Retracted A link between virulence and ecological abundance in natural populations of Staphylococcus aureus. Science (2001) 3.44
Role of interspecies transfer of chromosomal genes in the evolution of penicillin resistance in pathogenic and commensal Neisseria species. J Mol Evol (1992) 3.44
Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). Fed Proc (1976) 3.19
Clinical trial of disodium cromoglycate in treatment of asthma in children. Br Med J (1968) 3.10
Solving the structure of human H ferritin by genetically engineering intermolecular crystal contacts. Nature (1991) 3.10
Prevalence and Natural History of Asthma in Schoolchildren. Br Med J (1961) 3.07
Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type alpha and type beta transforming growth factors. Proc Natl Acad Sci U S A (1983) 3.02
Extrapyramidal reactions with metoclopramide. Br Med J (Clin Res Ed) (1985) 2.97
Ferritin: design and formation of an iron-storage molecule. Philos Trans R Soc Lond B Biol Sci (1984) 2.94
Attitudinal survey of voluntary reporting of adverse drug reactions. Br J Clin Pharmacol (1999) 2.78
Polarity and the regulation of the ilv gene cluster in Escherichia coli strain K-12. Mol Gen Genet (1976) 2.78
Expression of transforming growth factor-beta 1 in specific cells and tissues of adult and neonatal mice. J Cell Biol (1989) 2.77
Comprehensive clinical drug information service: first year's experience. Br Med J (1977) 2.77
What use is sex? J Theor Biol (1971) 2.75
Setting standards of prescribing performance in primary care: use of a consensus group of general practitioners and application of standards to practices in the north of England. Br J Gen Pract (1996) 2.75
Synergistic interaction of two classes of transforming growth factors from murine sarcoma cells. Cancer Res (1982) 2.70
Quinine toxicity. Adverse Drug React Acute Poisoning Rev (1986) 2.69
The prevalence of asthma and wheezing in children. Br J Dis Chest (1976) 2.60
The failings of NICE. Reply from chairman of NICE. BMJ (2001) 2.55
Activity of aryl hydrocarbon hydroxylase in psoriatic skin. Lancet (1979) 2.54
Clinical pharmacology in the National Health Service. J R Soc Med (1978) 2.54
Non-steroidal anti-inflammatory drugs and elderly patients. BMJ (1995) 2.53
Attitudes to adverse drug reaction reporting in the Northern Region. Br J Clin Pharmacol (1992) 2.51
Prescribing at the interface between hospitals and general practitioners. BMJ (1992) 2.47
The major evolutionary transitions. Nature (1995) 2.46
The role of the pharmaceutical industry in postgraduate medical education. Br J Clin Pharmacol (1977) 2.45
Tardive dyskinesia: prevalence and risk factors, 1959 to 1979. Arch Gen Psychiatry (1982) 2.43
The Maudsley Addiction Profile (MAP): a brief instrument for assessing treatment outcome. Addiction (1998) 2.41
The selected list. BMJ (1993) 2.39
Validation of an algorithm combining haemoglobin A(1c) and fasting plasma glucose for diagnosis of diabetes mellitus in UK and Australian populations. Diabet Med (2009) 2.38
Nucleotide sequence of Escherichia coli purF and deduced amino acid sequence of glutamine phosphoribosylpyrophosphate amidotransferase. J Biol Chem (1982) 2.32
The hitch-hiking effect-a reply. Genet Res (1976) 2.30
Compulsive buying: a report of 20 cases. J Clin Psychiatry (1994) 2.29
Clinical pharmacology clinics in general practice. Br Med J (1977) 2.28
Extraction and high-performance liquid chromatographic method for the determination of microcystins in raw and treated waters. Analyst (1994) 2.27
Beat-to-beat repolarization lability identifies patients at risk for sudden cardiac death. J Cardiovasc Electrophysiol (1998) 2.25
Paracetamol toxicity: epidemiology, prevention and costs to the health-care system. QJM (2002) 2.22
Pharmacy beyond the dispensary: general practitioners' views. BMJ (1992) 2.22
Parental perceptions of overweight in 3-5 y olds. Int J Obes (Lond) (2005) 2.21
Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of skeletal muscle and dermis derived from fetal, adult, and geriatric donors. Anat Rec (2001) 2.18
A survey of intravenous drug administration by preregistration house officers. BMJ (1993) 2.17
Role of Donnan equilibrium in the resting potentials in glycerol-extracted muscle. Am J Physiol (1971) 2.16
Pharmacokinetic and concentration-effect studies with intravenous metoclopramide. Br J Clin Pharmacol (1978) 2.14
OPTN/SRTR 2013 Annual Data Report: kidney. Am J Transplant (2015) 2.11
A prescribing incentive scheme for non-fundholding general practices: an observational study. BMJ (1996) 2.09
Doctors and the drug makers. Lancet (1984) 2.09
Difference in effects of end-plate potentials between procaine and lidocaine as revealed by voltage-clamp experiments. J Neurophysiol (1971) 2.08
Venous leg ulcers: a prognostic index to predict time to healing. BMJ (1992) 2.05
Perforation of the bladder: a complication of long-dwelling Foley catheter. J Urol (1973) 2.05
Extending the role of the community pharmacist. BMJ (1991) 2.05
OPTN/SRTR 2012 Annual Data Report: kidney. Am J Transplant (2014) 2.01
Diagnosis and etiology of congenital muscular dystrophy. Neurology (2007) 1.96
Factors affecting warfarin requirements. A prospective population study. Eur J Clin Pharmacol (1979) 1.95
Effects on the right ventricle, pulmonary vasculature, and carotid bodies of the rat of exposure to, and recovery from, simulated high altitude. Thorax (1973) 1.95
Survival advantage of pediatric recipients of a first kidney transplant among children awaiting kidney transplantation. Am J Transplant (2008) 1.94
Patent threat to research. Nature (1997) 1.93
Obstructive appendicopathy: a disease or a congenital entity? J Clin Pathol (2008) 1.93
Comparison of prescribing unit with index including both age and sex in assessing general practice prescribing costs. BMJ (1993) 1.90
Schistosome satellite DNA encodes active hammerhead ribozymes. Mol Cell Biol (1998) 1.89
Endotoxin-mediated dendritic cell release from the intestine. Characterization of released dendritic cells and TNF dependence. J Immunol (1995) 1.88
Nucleotide sequence analysis of the purEK operon encoding 5'-phosphoribosyl-5-aminoimidazole carboxylase of Escherichia coli K-12. J Bacteriol (1989) 1.88
Generalised tissue abnormality of aryl hydrocarbon hydroxylase in psoriasis. Br Med J (1980) 1.87
Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatotoxic adverse drug reactions. J Hepatol (2000) 1.84
OPTN/SRTR 2011 Annual Data Report: kidney. Am J Transplant (2013) 1.84
Screen detected high blood pressure under 40: a general practice population followed up for 21 years. BMJ (1993) 1.82
Congenital absence of the vagina. The Mayer-Rokitansky-Kuster-Hauser syndrome. Ann Intern Med (1976) 1.81